Clinical trials
Phase 3 Peripheral Arterial Disease trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 2 |
| AstraZeneca | 1 |
| CSL Behring | 1 |
| Eli Lilly and Company | 1 |
| Korea United Pharm. Inc. | 1 |
| SK Chemicals Co., Ltd. | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peripheral Arterial Disease | 8 |
| Coronary Artery Disease | 2 |
| Heart Diseases | 2 |
| Stroke | 2 |
| Acute Coronary Syndrome | 1 |
| Angina Pectoris | 1 |
| Atherosclerosis | 1 |
| Atrial Fibrillation | 1 |
| Cardiovascular Diseases | 1 |
| Chronic Limb-Threatening Ischemia | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.